IFI-M · US Sequential Integration Series

Specimen SS-F-M2-05801 // MULTI-AXIS · IFI-M

US Sequential Integration Series IV-BL-B

Solanum lycopersicum

Tomato

Tier IVUS Sequential Integration Series

Target Trait

3.3×

fold-change

Umami+Sweet sequential pathway fold-change

Technical Specifications

SKU

SS-F-M2-05801

Genomic Edits

10

GC Content

45.8%

Construct Length

5,141 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

mGluR1 + TAS1R2/TAS1R3

IFI Score

330

Pathway Edits

  • mGluR1 pathway primary gene cluster overexpression for umami axis activation
  • TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
  • Bidirectional promoter system for synchronized U+S dual-axis co-expression
  • Metabolic flux partitioning between IFI-U and IFI-S pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Umami-Sweet combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for U+S simultaneous accumulation
  • Cofactor balance optimization for U+S dual-pathway operation
  • Protein scaffold engineering for U+S enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized mGluR1 and TAS1R2/TAS1R3 pathway engineeringMetabolic flux partitioning strategy enabling simultaneous umami and sweet accumulation without competing pathway suppressionSequential construct stacking for US multi-axis integrationBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV US dual-axis sequential integration platform for food ingredient applications requiring verified combined umami+sweet sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$4049 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities